Laser Treatment of Basal Cell Carcinoma

NCT04936932 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2022-12-08

No results posted yet for this study

Summary

Laser treatment of Basal cell carcinoma

Conditions

Interventions

DEVICE

1064 nm long-pulse Nd:YAG laser

BCC lesion will be treated with long-pulse 1064 laser

DEVICE

1064 nm long-pulse Nd:YAG laser

BCC lesion will be treated with long-pulse 1064 laser

Sponsors & Collaborators

  • Sciton

    lead INDUSTRY

Principal Investigators

  • Chris Robb, MD · Skin & Allergy Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-08-20
Completion
2022-08-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04936932 on ClinicalTrials.gov